Robuta

https://www.als-mnd.org/support-for-pals-cals/research/us-fda-orphan-drug-designation/ US FDA Orphan Drug Designation orphan drug designationus fda https://www.regmednet.com/cell-therapy-weekly-orphan-drug-designation-for-brain-cancer-car-t-cell-therapy/ Cell Therapy Weekly: Orphan Drug Designation for CAR-T Therapy - RegMedNet Jul 11, 2025 - Mustang Bio's CAR T-cell therapy MB-101 for astrocytoma and glioblastoma has received Orphan Drug Designation. orphan drug designationcell therapyfor carweekly https://www.sanofi.com/en/media-room/press-releases/2026/2026-03-02-06-00-00-3247008 Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related... Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 study of rilzabrutinib... orphan drug designationpress releasein japan https://elixirgentx.com/elixirgen-therapeutics-granted-fda-orphan-drug-designation-for-exg-34217-for-treatment-of-telomere-biology-disorders/ Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere... BALTIMORE, February 20, 2025 – Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the... orphan drug designationtherapeuticsgrantedfdatreatment https://en.cmicgroup.com/news-events/notice-regarding-designation-as-an-orphan-drug-and-supplemental-new-drug-application-for-sodium-phenylbutyrate-for-designated-intractable-disease-progressive-familial-intrahepatic-cholestasis-pfic/ Notice regarding Designation as an Orphan Drug and Supplemental New Drug Application for Sodium... Oct 16, 2025 - Notice regarding Designation as an Orphan Drug and Supplemental New [...] orphan drugnew application